Thromboxane Modulating Agents. Part 4. Design and Synthesis of 3-(2-[{(4-Chlorophenyl)sulfonyl}amino]ethyl)benzenepropanoic Acid Derivatives as Potent Thromboxane Receptor Antagonists.